Bilateral Multifocal Eyelid Tuberculosis Recurrent Chalazia:A Case Report
This case report describes a rare instance of bilateral multifocal eyelid tuberculosis mimicking recurrent chalazia in a 36-year-old woman, highlighting the critical need for integrating histopathology and specific laboratory testing to avoid misdiagnosis and ensure successful treatment with standard anti-tuberculosis therapy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human body is a complex system where infections usually announce themselves with familiar signs: a fever, a cough, or a red, swollen eye that feels like a stye. Most of the time, when a lump appears on an eyelid, doctors and patients alike assume it is a blocked oil gland, a common condition often called a chalazion. These lumps are usually harmless, sometimes painful, and typically resolve with warm compresses or a simple surgical removal. However, there is a rare and stubborn exception to this rule. Tuberculosis, a disease most people associate with the lungs and a persistent cough, can sometimes travel through the blood to settle in unexpected places, including the skin and the delicate tissues around the eye. When this happens, the infection does not always look like the classic disease; it can mimic common eyelid problems so closely that it tricks even experienced doctors, leading to repeated surgeries that fail to cure the patient because the underlying cause remains untreated.
This story begins with a thirty-six-year-old woman who came to a hospital in Nanchang, China, complaining of a painless lump on her left eyelid that had been growing for a month. She was healthy in every other way, with no history of lung problems or exposure to tuberculosis. At first, the doctors treated her as they would any patient with a stubborn eyelid mass. They removed the lump and the surrounding tissue, expecting the problem to be solved. But the body told a different story. Within a week, the lump returned on the left side, and new lumps began to appear on the right eyelid as well. The condition spread, with multiple nodules forming on both upper and lower lids, some of which developed into open sores covered in yellow crusts. The inside of her eyelids, the conjunctiva, became inflamed and covered in fragile, bleeding bumps. It was becoming clear that this was not a simple blocked gland, but something more complex and persistent.
The medical team performed a second surgery to remove the new growths and sent the tissue to a laboratory for a closer look. Under a microscope, the cells looked like a fortress under siege: they were packed with immune cells trying to fight an intruder, forming structures known as granulomas. However, the usual signs of a standard bacterial infection were missing, and the tests for common germs came back negative. The tissue did not contain the dead, cheese-like material often seen in classic tuberculosis, which made the diagnosis even harder. The patient was then referred to a specialist clinic for tuberculosis screening. Here, the investigation shifted from the eye to the body's immune memory. Blood tests revealed that her immune system had encountered the tuberculosis bacteria at some point, showing a strong reaction to specific proteins found in the germ. While a scan of her lungs showed only tiny, inactive spots and no active infection in her chest, the combination of the recurring eye lumps, the specific immune response, and the failure of standard antibiotics pointed to a single conclusion: she had tuberculosis in her eyelids.
Once the diagnosis was made, the treatment changed completely. Instead of just cutting out the lumps, the patient began a strict, four-month course of four different antibiotics designed specifically to kill the tuberculosis bacteria. She also took medication to protect her liver, a common precaution with these powerful drugs. During the first two months, she took all four medicines; for the next four months, she continued with two of them. Even as the medication worked, the lump on her right eye grew large enough to require a second surgical removal to relieve pressure and clear the infection. The results were striking. One month after starting the drugs, the swelling began to go down. By the three-month mark, the eyelids looked nearly normal, and the hard lumps had disappeared. At the six-month follow-up, the woman's eyes were completely clear, with no sign of the masses returning.
This case highlights a difficult reality in medicine: when a common problem behaves strangely, it may be a rare disease in disguise. The researchers found that eyelid tuberculosis is often missed because it looks so much like a simple chalazion, and because the bacteria are present in such low numbers that they are hard to detect with standard tests. The key to solving the mystery was not just looking at the eye, but understanding the pattern of recurrence and using blood tests to see what the immune system knew. The study suggests that for any patient with eyelid lumps that keep coming back after surgery, especially if they appear on both sides, doctors should consider tuberculosis as a possibility. By recognizing the signs early and starting the correct treatment, a condition that could have led to permanent damage or chronic illness can be cured completely.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.